Looking at the benefits of antiretroviral resistance testing in HIV-positive people. https://t.co/roqd6c4rky #WorldAIDSDay @CochraneAfrica
The results of a new Cochrane review suggest we should be more selective picking which patients with #HIV get antiretroviral resistance testing https://t.co/sqv1nDpDJ9
More research needed on #antiretroviral resistance testing in treatment‐naive people with #HIV with high rates of transmitted drug resistance @CochraneLibrary https://t.co/7eJybA1J1K
RT @CochraneIberoam: Nueva revisión de @Cochrane_IDG : “Pruebas de resistencia antirretroviral en pacientes con pruebas positivas para VIH…
RT @CochraneIberoam: Nueva revisión de @Cochrane_IDG : “Pruebas de resistencia antirretroviral en pacientes con pruebas positivas para VIH…
Nueva revisión de @Cochrane_IDG : “Pruebas de resistencia antirretroviral en pacientes con pruebas positivas para VIH ”. https://t.co/6NBL1TAEMq Once EC (publicados entre 1999 i 2006), que incluyeron 2531 pacientes. #VIH #AIDS
New @Cochrane_IDG Review - Antiretroviral resistance testing in HIV‐positive people https://t.co/3AGQuXlwFE Eleven RCTs (published between 1999 and 2006), which included 2531 participants. #HIV #AIDS https://t.co/V7bW3BEiYT
RT @CochraneUK: New @Cochrane_IDG Review - Antiretroviral resistance testing in HIV‐positive people https://t.co/7x4RnlgVvj Eleven RCTs (pu…
Newly published Cochrane review investigates antiretroviral resistance testing in people living with #HIV. https://t.co/qXIDPm0SKU https://t.co/pJEIuYmYPE
I know this bit off the topic But dodge you that New HIV drug Gammora passed its first human clinical trial eliminating 99% of the virus within 4 weeks of treatment.